REGENXBIO Inc.
RGNX· Nasdaq
RGNXREGENXBIO Inc.
Filed Nov 5, 2015 · 10-Q · 36 days after period end · 0001193125-15-367340
| Metric | Q3 2015 | Q3 2014 |
|---|---|---|
| Revenue | $1.14M | $483.00K |
| Net Income | -$7.33M | -$1.79M |
| EPS Diluted | -$1.52 | -$0.73 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
REGENXBIO Inc. · CIK 1590877 · Engraved from SEC EDGAR
ended Sep 30, 2015 · filed Nov 5, 2015 · 36 d after period end
